In this mini-series of talks, we will survey some recent advances in utilizing advances in machine learning to help tackle challenging tasks in scientific computing, focusing on numerical methods for solving high dimensional partial differential equations and high dimensional sampling problems. In particular, we will discuss theoretical understandings and guarantees for such methods and new challenges arise from the perspective of numerical analysis.



 



In the second lecture, we will discuss numerical approach to solve high dimensional Hamilton-Jacobi-Bellman (HJB) type partial differential equations (PDEs). The HJB PDEs, reformulated as optimal control problems, are tackled by the actor-critic framework inspired by reinforcement learning, based on neural network parametrization of the value and control functions. Within the actor-critic framework, we employ a policy gradient approach to improve the control, while for the value function, we derive a variance reduced least-squares temporal difference method using stochastic calculus. We will also discuss convergence analysis for the actor-critic method, in particular the policy gradient method for solving stochastic optimal control.

7月21日
10:00am - 11:00am
地點
Room 2302 (Lifts 17/18)
講者/表演者
Prof. Jianfeng LU
Duke University
主辦單位
Department of Mathematics
聯絡方法
付款詳情
對象
Alumni, Faculty and staff, PG students, UG students
語言
英語
其他活動
1月6日
研討會, 演講, 講座
IAS / School of Science Joint Lecture - Innovations in Organo Rare-Earth and Titanium Chemistry: From Self-Healing Polymers to N2 Activation
Abstract In this lecture, the speaker will introduce their recent studies on the development of innovative organometallic complexes and catalysts aimed at realizing unprecedented chemical trans...
12月5日
研討會, 演講, 講座
IAS / School of Science Joint Lecture - Human B Cell Receptor-Epitope Selection for Pan-Sarbecovirus Neutralization
Abstract The induction of broadly neutralizing antibodies (bnAbs) against viruses requires the specific activation of human B cell receptors (BCRs) by viral epitopes. Following BCR activation, ...